Remission as the treatment goal – the FIN-RACo trial

Clinical and Experimental Rheumatology

P. Hannonen¹  T. Möttönen¹  H. Mäkinen¹    Authors: T. Sokka¹  K. Puolakka¹ 

关键词: Remission;    rheumatoid arthritis;   

DOI  :  

学科分类：医学（综合）

来源: Pacini Editore SpA

【 摘 要 】

ABSTRACT: The Finnish Rheumatoid Arthritis Combination Therapy (FIN-RACo) trial is the first rheumatoid arthritis (RA) clinical trial in which remission served as the primary outcome measure. This chapter reviews the philosophical background, study design, and results of the FIN-RACo trial. The study showed that a third of patients with active early RA may achieve remission with a combination of methotrexate (MTX), sulfasalazine (SSZ), hydroxychloroquine (HCQ), and prednisolone.

【 授权许可】

Unknown